Results 191 to 200 of about 1,013 (224)

Finding novel vulnerabilities of hypomorphic BRCA1 alleles

open access: yesMolecular Oncology, EarlyView.
Synthetic lethality screens performed to identify novel vulnerabilities often model complete gene loss, thereby overlooking patient‐derived hypomorphic mutations. In this study, we have performed genome‐wide CRISPR screens on BRCA1 hypomorphic mutations, showing BRCA1I26A behaves like wild‐type, while BRCA1R1699Q mimics deficiency. Furthermore, we have
Anne Schreuder   +10 more
wiley   +1 more source

Longitudinal genome‐wide aneuploidy measurements in circulating cell‐free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancer

open access: yesMolecular Oncology, EarlyView.
Many patients with urothelial cancer do not benefit from treatment with pembrolizumab, while at risk of severe side effects. Changes in the levels of circulating tumor DNA early during treatment, measured by a simple and affordable assay that can be easily implemented in the clinic, can be used as a prognostic tool to identify these patients.
Youssra Salhi   +14 more
wiley   +1 more source

The research of the novel bearingless levitation system based on Extended State Observer (ESO)

2011 International Conference on Electrical Machines and Systems, 2011
At present, the classical control strategy of PID is widely adopted in the bearingless levitation system. However, it is hard to realize high performance of levitation control, due to the influence of disturbance, parameters perturbation etc. Aiming at the problem above, the novel bearingless levitation system based on Extended State Observer (ESO) is ...
Peng He, Xiaolin Wang
openaire   +1 more source

Home - About - Disclaimer - Privacy